Search

Your search keyword '"H. Abdel Hamid"' showing total 200 results

Search Constraints

Start Over You searched for: Author "H. Abdel Hamid" Remove constraint Author: "H. Abdel Hamid"
200 results on '"H. Abdel Hamid"'

Search Results

151. New 1,2,4-oxadiazole derivatives as potential multifunctional agents for the treatment of Alzheimer's disease: design, synthesis, and biological evaluation.

153. Design and Synthesis of Quinoxaline Hybrids as Modulators of HIF-1a, VEGF, and p21 for Halting Colorectal Cancer.

154. Targeting EGFR/PI3K/AKT/mTOR signaling in lung and colon cancers: synthesis, antitumor evaluation of new 1,2,4-oxdiazoles tethered 1,2,3-triazoles.

155. Design, synthesis, and biological evaluation of 1,2,4-oxadiazole-based derivatives as multitarget anti-Alzheimer agents.

156. Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation.

157. Challenging the anticolorectal cancer capacity of quinoxaline-based scaffold via triazole ligation unveiled new efficient dual VEGFR-2/MAO-B inhibitors.

158. Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer.

159. Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential.

160. Preparation, Characterization of New Antimicrobial Antitumor Hybrid Semi-Organic Single Crystals of Proline Amino Acid Doped by Silver Nanoparticles.

161. 4-( N -Phthalimido)phenyl Isonitrile as a Novel Convertible Isocyanide Analogue with the Odorless Property as an Extra Bonus.

162. Nature-inspired new isoindole-based Passerini adducts as efficient tumor-selective apoptotic inducers via caspase-3/7 activation.

163. Structure optimization of new tumor-selective Passerini α-acyloxy carboxamides as Caspase-3/7 activators.

164. Synthesis of a new magnetic Sulfacetamide-Ethylacetoacetate hydrazone-chitosan Schiff-base for Cr(VI) removal.

166. Role of endoscopic ultrasound and cyst fluid tumor markers in diagnosis of pancreatic cystic lesions.

167. Exploration of Nitroaromatic Antibiotics via Sanger's Reagent: Synthesis, In Silico , and Antimicrobial Evaluation.

168. Beyond direct Nrf2 activation; reinvestigating 1,2,4-oxadiazole scaffold as a master key unlocking the antioxidant cellular machinery for cancer therapy.

169. Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications.

170. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.

171. Biomphalaria alexandrina: a model organism for assessing the endocrine disrupting effect of 17β-estradiol.

172. Design, synthesis and biological evaluation of novel α-acyloxy carboxamides via Passerini reaction as caspase 3/7 activators.

173. Video-assisted thoracoscopic thymectomy for non-thymomatous myasthenia gravis: a right-sided or left-sided approach?

175. A rare cause of reversible ophthalmoplegia: tension pneumocephalus with brainstem compression.

176. Studies on the effect of pollution on Lake Manzala ecosystem in Port-Said, Damietta and Dakahlia Governorates Egypt.

177. Combined Vascular and Orthopaedic Approach for a Pseudotumor Causing Deep Vein Thrombosis after Metal-on-Metal Hip Resurfacing Arthroplasty.

178. Biological and hematological responses of Biomphalaria alexandrina to mycobiosynthsis silver nanoparticles.

179. Child neurology: tick paralysis: a diagnosis not to miss.

180. A suppressor screen of the chimeric AtCNGC11/12 reveals residues important for intersubunit interactions of cyclic nucleotide-gated ion channels.

182. Pharmacological therapies for muscular dystrophies.

183. A global perspective on irritable bowel syndrome: a consensus statement of the World Gastroenterology Organisation Summit Task Force on irritable bowel syndrome.

184. High throughput chemical screening supports the involvement of Ca2+ in cyclic nucleotide-gated ion channel-mediated programmed cell death in Arabidopsis.

185. A copy number variation morbidity map of developmental delay.

186. Calmodulin binding to Arabidopsis cyclic nucleotide gated ion channels.

187. Neuromuscular pathology unknown.

188. Importance of the alphaC-helix in the cyclic nucleotide binding domain for the stable channel regulation and function of cyclic nucleotide gated ion channels in Arabidopsis.

189. Neurologic manifestations of transplant complications.

190. Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome.

191. Severe hydroxychloroquine myopathy.

192. Novel regioselective formation of S- and N-hydroxyl-alkyls of 5-(3-chlorobenzo[b]thien-2-yl)-3-mercapto-4H-1,2,4-triazole and a facile synthesis of triazolo-thiazoles and thiazolo-triazoles. Role of catalyst and microwave.

193. Evaluation of cDNA libraries from different developmental stages of Schistosoma mansoni for production of expressed sequence tags (ESTs).

194. The value of combined use of N-butyl-2-cyanoacrylate and ethanolamine oleate in the management of bleeding esophagogastric varices.

195. Biological monitoring of occupational exposure to electrophilic compounds.

196. Magnetic resonance imaging of the female bony pelvis: MRI pelvimetry.

197. Magnetic resonance imaging (MRI) of abnormal uterine masses.

198. "Judaicine"; a new anti-anginal drug.

Catalog

Books, media, physical & digital resources